These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30726714)

  • 1. Doxycycline and Ursodiol for ATTR Amyloidosis: Not Ready for Prime Time.
    Witteles RM
    J Card Fail; 2019 Mar; 25(3):154-155. PubMed ID: 30726714
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis.
    Karlstedt E; Jimenez-Zepeda V; Howlett JG; White JA; Fine NM
    J Card Fail; 2019 Mar; 25(3):147-153. PubMed ID: 30660664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
    Wixner J; Pilebro B; Lundgren HE; Olsson M; Anan I
    Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosis.
    Panhwar MS; Al-Kindi S; Oliveira GH; Ginwalla M
    Amyloid; 2017 Dec; 24(4):217-218. PubMed ID: 28868918
    [No Abstract]   [Full Text] [Related]  

  • 5. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis.
    Singh A; Geller HI; Falk RH
    J Am Coll Cardiol; 2017 Feb; 69(6):757-758. PubMed ID: 28183520
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxycycline-tauroursodeoxycholic acid treatment: effects in the heart of a transthyretin V30M transgenic mouse model.
    Teixeira C; Costelha S; Martins HS; Teixeira A; Saraiva MJ
    Amyloid; 2017 Mar; 24(sup1):80. PubMed ID: 28434372
    [No Abstract]   [Full Text] [Related]  

  • 9. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
    Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
    Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.
    Sumi-Akamaru H; Eto M; Yamauchi A; Uehara T; Kakuda K; Obayashi K; Kato S; Naka T; Mochizuki H
    Neuropathology; 2018 Feb; 38(1):11-21. PubMed ID: 28960480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies.
    Jamet MP; Gnemmi V; Hachulla É; Dhaenens CM; Bouchindhomme B; Delattre C; Glowacki F; Hatron PY; Lacour A; Lamblin N; Launay D; Leleu X; Guiochon-Mantel A; Valleix S; Maurage CA; Copin MC; Buob D
    Am J Surg Pathol; 2015 Aug; 39(8):1035-44. PubMed ID: 25828388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transthyretin-related hereditary amyloidosis].
    Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D
    Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients.
    Nakagawa M; Sekijima Y; Tojo K; Ikeda S
    Amyloid; 2013 Jun; 20(2):138-40. PubMed ID: 23638696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenging histological diagnosis of transthyretin (ATTR) amyloidosis.
    Charkhkar E; Westermark P
    Amyloid; 2017 Mar; 24(sup1):130-131. PubMed ID: 28434352
    [No Abstract]   [Full Text] [Related]  

  • 17. How to ATTR-ACT the perfect match?
    Bonderman D
    Eur J Heart Fail; 2021 Feb; 23(2):275-276. PubMed ID: 33342016
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study.
    Obici L; Cortese A; Lozza A; Lucchetti J; Gobbi M; Palladini G; Perlini S; Saraiva MJ; Merlini G
    Amyloid; 2012 Jun; 19 Suppl 1():34-6. PubMed ID: 22551192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
    Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
    Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary ATTR amyloidosis: a single-institution experience with 266 patients.
    Swiecicki PL; Zhen DB; Mauermann ML; Kyle RA; Zeldenrust SR; Grogan M; Dispenzieri A; Gertz MA
    Amyloid; 2015; 22(2):123-31. PubMed ID: 26017327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.